You are here
The content on this page and other TGA archive pages is provided to assist research and may contain references to activities or policies that have no current application. See the full archive disclaimer.
CMEC Meeting 47, 13 August 2004
Complementary Medicines Evaluation Committee
Extracted ratified minutes
Public recommendation summary
This summary has been posted immediately after the CMEC meeting to give quick advice of the recommendations made by CMEC to the TGA. This summary does not represent the decisions of TGA. Reasons underlying these recommendations will be available after Members ratify the Minutes at the next CMEC meeting.
CMEC confirms that the draft Minutes of its previous meeting (CMEC 46, 11 June 2004), as amended, are a true and accurate record of that previous meeting.
Item 6.1 Application for the evaluation of a new substance - Digestive enzymes: amylase, tilactase, protease derived from Aspergillus oryzae; cellulase derived from Trichoderma longibrachiatum; and lipase derived from Rhizopus oryzae
CMEC recommends to the TGA that the following enzymes:
- amylase, tilactase, protease derived from Aspergillus oryzae;
- cellulase derived from Trichoderma longibrachiatum;
- and lipase derived from Rhizopus oryzae
are suitable for use as active ingredients in Listed medicines.
CMEC notes the proposal by the Office of Complementary Medicines to permit the use of curcumin as an active ingredient in Listed medicines.